COMMUNIQUÉS West-GlobeNewswire

Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement
15/05/2025
GERMANTOWN, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose [...]
Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
15/05/2025
Emrosi™ commercial launch initiated for the treatment of inflammatory lesions of rosacea in adults Fortress subsidiary Checkpoint Therapeutics to be acquired by Sun Pharma; special meeting of Checkpoint stockholders to [...]
Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025
15/05/2025
New Analysis Shows Treatment with Investigational Paltusotine Resulted in Rapid and Durable IGF-1 Control in Surgically Naïve Acromegaly Patients Additional Research Includes Acromegaly Symptom Burden and Standard-of- [...]
Reviva Reports First Quarter 2025 Financial Results and Recent Business Highlights
15/05/2025
– 446 participants completed the brilaroxazine long-term open-label extension (OLE) trial with 156 completing one-year and 301 completing six months of treatment – – Full data set from RECOVER OLE highlighting clinical [...]
SRx Health Solutions Announces First Quarter 2025 Financial Results
15/05/2025
EPS Improved 90% Year-Over-Year to $(0.37) Adjusted EBITDA 1 Loss Improved 54% Year-Over-Year to $(0.6) Million Adjusted EBITDA Margin 1 Improved (9)% , a 865 Basis Point Expansion Year-Over-Year TAMPA, Fla., May 15, [...]
vTv Therapeutics Announces 2025 First Quarter Financial Results and Provides Corporate Update
15/05/2025
Ongoing screening in CATT1 Phase 3 trial evaluating cadisegliatin in patients with type 1 diabetes (T1D) Topline Phase 3 data for cadisegliatin expected in 2H 2026 HIGH POINT, N.C., May 15, 2025 (GLOBE NEWSWIRE) -- vTv [...]
Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
15/05/2025
Patient dosing initiated in Phase 1 CALiPSO-1 trial evaluating CNTY-101 in autoimmune disease; expanding to additional U.S. and European sites following CTA authorizations in Germany, France, and Italy CNTY-308 expected [...]
Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results
15/05/2025
Announced Global Collaboration with Novo Nordisk to Develop Oral Small Molecules for Metabolic Diseases with Over $2.2 Billion in Potential Milestone Payments On Track to Select a Next-Generation Oral Small Molecule [...]
Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2025 and Provides Corporate Update
15/05/2025
LYTENAVA™ (bevacizumab gamma) on track for planned first commercial launches in Germany and the United Kingdom (UK) in Q2 CY2025 Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 in the United States [...]
Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update
15/05/2025
DUBLIN, May 15, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, today [...]
Dianabol (Dbol) For Sale 2025: Best Legal Dbol Pills, Cycles & Stacking Guide
15/05/2025
Looking for Dianabol in 2025? Find legal Dbol pills, smart stacking advice, and trusted options for muscle and recovery support backed by Wolfson Brands (UK) Limited New York City, NY, May 15, 2025 (GLOBE NEWSWIRE) -- [...]
Best SARMs For Sale: Buy Legal SARMs For Bodybuilding & Cutting Cycles - Crazybulk
15/05/2025
Bodybuilding support made simple. Find top SARMs for sale, ideal for cutting or bulking cycles, all with legal, safe alternatives in one guide by Crazybulk New York City, NY, May 15, 2025 (GLOBE NEWSWIRE) -- [...]
Best Testosterone Booster for Men – Why TestoPrime is the Top Choice for Libido, Performance, and Vitality
15/05/2025
Explore how TestoPrime naturally enhances testosterone to improve energy, improve libido, sexual health and support performance, offering a safe and effective alternative to conventional treatments for Erectile [...]
Philips successfully prices offering of Notes for EUR 1 billion to be used for repayment of existing debt and to finance eligible green projects
15/05/2025
May 15, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 500 million fixed rate notes due 2030 [...]
RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven
15/05/2025
CHICAGO, May 15, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of [...]
Arialief Criticism Reviewed: The Tainted Neuropathy Relief Controversy Published
15/05/2025
Unmasking the Truth About Arialief: Honest Reviews, Ingredient Warnings, and the Real Reasons Behind User Complaints In This Arialief Review, You’ll Discover: What Arialief is and how Arialief is marketed as a top [...]
Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments
15/05/2025
Federal court jury found Amgen liable for violating antitrust and tort laws by using cross-therapeutic bundled rebates to prevent Praluent ® (alirocumab) from competing in the market Jury awarded Regeneron $135.6 [...]
Sanofi: Information concerning the total number of voting rights and shares - April 2025
15/05/2025
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Avril 2025
15/05/2025
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]

Pages